Organigram Holdings Future Growth
Future criteria checks 4/6
Organigram Holdings is forecast to grow earnings and revenue by 143.5% and 16.5% per annum respectively while EPS is expected to grow by 142.5% per annum.
Key information
143.5%
Earnings growth rate
142.5%
EPS growth rate
| Pharmaceuticals earnings growth | 21.6% |
| Revenue growth rate | 16.5% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 11 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2027 | 295 | N/A | N/A | N/A | 1 |
| 9/30/2026 | 205 | -5 | -4 | N/A | 2 |
| 9/30/2025 | 184 | 3 | -3 | 4 | 7 |
| 9/30/2024 | 160 | -43 | -16 | -15 | 7 |
| 9/30/2023 | 149 | -229 | -64 | -36 | N/A |
| 5/31/2023 | 161 | -222 | -80 | -41 | N/A |
| 2/28/2023 | 166 | -11 | -89 | -42 | N/A |
| 11/30/2022 | 159 | -8 | -74 | -23 | N/A |
| 8/31/2022 | 146 | -14 | -85 | -36 | N/A |
| 5/31/2022 | 125 | -34 | -63 | -24 | N/A |
| 2/28/2022 | 107 | -35 | -53 | -29 | N/A |
| 11/30/2021 | 90 | -98 | -56 | -38 | N/A |
| 8/31/2021 | 79 | -131 | -41 | -29 | N/A |
| 5/31/2021 | 75 | -143 | -44 | -29 | N/A |
| 2/28/2021 | 72 | -229 | -46 | -17 | N/A |
| 11/30/2020 | 81 | -170 | -80 | -18 | N/A |
| 8/31/2020 | 87 | -136 | -124 | -45 | N/A |
| 5/31/2020 | 83 | -120 | -156 | -53 | N/A |
| 2/29/2020 | 89 | -40 | -164 | -50 | N/A |
| 11/30/2019 | 93 | -40 | -154 | -47 | N/A |
| 8/31/2019 | 80 | -10 | -145 | -35 | N/A |
| 5/31/2019 | 67 | 31 | -121 | -26 | N/A |
| 2/28/2019 | 46 | 45 | -118 | -29 | N/A |
| 11/30/2018 | 22 | 53 | -96 | -24 | N/A |
| 8/31/2018 | 12 | 22 | -69 | -13 | N/A |
| 5/31/2018 | 11 | 2 | -60 | -10 | N/A |
| 2/28/2018 | 10 | -4 | -47 | -13 | N/A |
| 11/30/2017 | 6 | -11 | -41 | -14 | N/A |
| 8/31/2017 | 5 | -11 | N/A | -9 | N/A |
| 5/31/2017 | 5 | -8 | N/A | -5 | N/A |
| 2/28/2017 | 5 | -6 | N/A | -3 | N/A |
| 11/30/2016 | 7 | 0 | N/A | 0 | N/A |
| 8/31/2016 | 6 | 1 | N/A | -2 | N/A |
| 5/31/2016 | 5 | 0 | N/A | -2 | N/A |
| 2/29/2016 | 3 | 0 | N/A | -3 | N/A |
| 11/30/2015 | 2 | -1 | N/A | -2 | N/A |
| 8/31/2015 | 1 | -1 | N/A | -3 | N/A |
| 5/31/2015 | 0 | -9 | N/A | -2 | N/A |
| 2/28/2015 | 0 | -10 | N/A | -2 | N/A |
| 11/30/2014 | 0 | -9 | N/A | -2 | N/A |
| 8/31/2014 | N/A | -8 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0OG0 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: 0OG0 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0OG0 is expected to become profitable in the next 3 years.
Revenue vs Market: 0OG0's revenue (16.5% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 0OG0's revenue (16.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0OG0's Return on Equity is forecast to be high in 3 years time